Invion Limited (ASX:IVX)

Australia flag Australia · Delayed Price · Currency is AUD
0.0920
0.00 (0.00%)
Jan 28, 2026, 3:59 PM AEST
-55.12%
Market Cap7.88M
Revenue (ttm)n/a
Net Income-8.81M
EPS-0.12
Shares Out85.65M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume92,942
Average Volume136,607
Open0.0930
Previous Close0.0920
Day's Range0.0910 - 0.0940
52-Week Range0.0750 - 0.2250
Beta0.88
RSI52.24
Earnings DateFeb 24, 2026

About Invion

Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical... [Read more]

Sector Healthcare
Founded 2000
Employees 4
Stock Exchange Australian Securities Exchange
Ticker Symbol IVX
Full Company Profile

Financial Performance

Financial Statements